You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for New Drug Application (NDA): 209050


✉ Email this page to a colleague

« Back to Dashboard


NDA 209050 describes SORAFENIB TOSYLATE, which is a drug marketed by Dr Reddys, Mylan, Teva Pharms Usa Inc, Torrent, and Yabao Pharm, and is included in five NDAs. It is available from seven suppliers. Additional details are available on the SORAFENIB TOSYLATE profile page.

The generic ingredient in SORAFENIB TOSYLATE is sorafenib tosylate. There are thirteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the sorafenib tosylate profile page.
Summary for 209050
Tradename:SORAFENIB TOSYLATE
Applicant:Yabao Pharm
Ingredient:sorafenib tosylate
Patents:0
Pharmacology for NDA: 209050
Mechanism of ActionProtein Kinase Inhibitors
Suppliers and Packaging for NDA: 209050
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SORAFENIB TOSYLATE sorafenib tosylate TABLET;ORAL 209050 ANDA TWi Pharmaceuticals USA, Inc. 24979-715 24979-715-04 60 TABLET, FILM COATED in 1 BOTTLE (24979-715-04)
SORAFENIB TOSYLATE sorafenib tosylate TABLET;ORAL 209050 ANDA TWi Pharmaceuticals USA, Inc. 24979-715 24979-715-44 120 TABLET, FILM COATED in 1 BOTTLE (24979-715-44)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 200MG BASE
Approval Date:Nov 9, 2022TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.